US2016333086A1
|
|
Antigen binding proteins
|
US2018207172A1
|
|
Treatment for vitiligo
|
AU2016264023A1
|
|
Method of producing a recombinant protein
|
WO2016062624A1
|
|
Denture adhesive
|
WO2016059602A2
|
|
Combination therapy with anti-her3 antibodies to treat cancer
|
US2015247858A1
|
|
Methods for detecting LP-PLA2 activity and inhibition of LP-PLA2 activity
|
ZA201500053B
|
|
Inhaler device
|
GB201421744D0
|
|
Denture adhesive composition
|
AU2014268195A1
|
|
Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
|
US2017156359A1
|
|
Novel milk beverage composition comprising creatine
|
GB201409933D0
|
|
Novel device
|
AU2014202546A1
|
|
Improved anti-serum albumin binding variants
|
US2015202172A1
|
|
Novel method of use
|
GB201405509D0
|
|
Novel Device
|
GB201404700D0
|
|
Novel Composition
|
GB201403271D0
|
|
Novel beverage composition
|
GB201402988D0
|
|
Novel apparatus and process
|
AU2014200770A1
|
|
Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
|
WO2014124950A1
|
|
Novel composition
|
AU2014211438A1
|
|
Method of producing a protein
|